Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A (2006)
Weeks 4 through 8: introduction phase Begin retatrutide at the lowest available dose (0.5 to 1mg weekly) while continuing tesamorelin
ClinicalTrials.gov Identifier: NCT03613727
These side effects can occur due to a rapid escalation of dosage
Finally, many of the common prescription medications (including the aforementioned acid blockers, as well as antibiotics, synthetic estrogens, and even birth control pills ) we see as problematic for the thyroid, can also cause inflammation in the gut, further affecting our ability to extract nutrients from food, and result in nutrient deficiencies
Think of this as your cheat sheet for preserving peptide potency